Efficacy and safety of once-weekly dulaglutide in adult Chinese patients with type 2 diabetes and lower baseline body mass index.
J Diabetes
; 13(4): 353-357, 2021 Apr.
Article
em En
| MEDLINE
| ID: mdl-33325105
ABSTRACT
Highlights In Chinese patients with type 2 diabetes (T2D) and body mass index (BMI) <25 kg/m2 , dulaglutide demonstrated great improvements in glycemic control with mild body weight reduction and low hypoglycemia risk. The results indicate that dulaglutide is effective and safe in patients with T2D and lower BMI; therefore, BMI should not be a consideration when dulaglutide is prescribed to Chinese patients with T2D.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Glicemia
/
Proteínas Recombinantes de Fusão
/
Fragmentos Fc das Imunoglobulinas
/
Índice de Massa Corporal
/
Diabetes Mellitus Tipo 2
/
Peptídeos Semelhantes ao Glucagon
/
Incretinas
/
Controle Glicêmico
/
Hipoglicemiantes
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article